Tag: ISC 2026
Viz.ai highlights study demonstrating 44% reduction in interfacility stroke transfer times
Viz.ai has highlighted the presentation of new clinical data at last month’s International Stroke Conference (ISC; 4–6 February, New Orleans, USA) demonstrating a 44%...
Randomised trial results suggest tenecteplase’s late-window benefits do not extend to...
While new data have provided solid evidence on tenecteplase’s benefits in non-large vessel occlusion (LVO) ischaemic stroke patients presenting within 24 hours from symptom...
RapidAI announces ISC abstracts spanning aneurysm monitoring, stroke detection and radiology...
RapidAI has announced that it had a total of 28 scientific abstracts accepted and presented at the 2026 International Stroke Conference (ISC; 4–6 February, New Orleans, USA),...
Refined patient selection and tailored devices revitalise thrombectomy for MeVO stroke
Late-breaking data from two randomised controlled trials (RCTs) presented at this year’s International Stroke Conference (ISC; 4–6 February, New Orleans, USA) have found mechanical...
BCI-enabled stroke rehabilitation therapy significantly improves functional outcomes in randomised trial
Kandu has announced results from what it describes as the first randomised controlled trial (RCT) evaluating a US Food and Drug Administration (FDA)-cleared, non-invasive...
New clinical data demonstrate Aidoc algorithm’s ability to successfully detect medium-vessel...
Aidoc has announced the presentation of two new scientific abstracts comparing artificial intelligence (AI)-powered stroke solutions at this year’s International Stroke Conference (ISC; 4–6...
MMAe reduces poor clinical outcomes or need for surgery twofold in...
Middle meningeal artery embolisation (MMAe) has been shown to result in the twofold reduction of a study endpoint including poor clinical outcomes and need...
Novel dual-functional therapy leads to clinical improvements in patients with disabling...
Lumosa Therapeutics has announced positive results from two independent Phase 2 clinical trials of its novel stroke drug LT3001 (odatroltide). LT3001 is described by...
Positive loberamisal data underscore potential role for multi-target neuroprotective agents in...
Stroke patients who intravenously received the novel neuroprotective medication loberamisal (NeuroDawn Pharmaceutical) on a daily basis—for 10 days and starting within 48 hours of...
Investigational Factor XIa inhibitor achieves reduction in secondary ischaemic stroke
The investigational anti-clotting medication asundexian (Bayer) has demonstrated a reduction in the risk of a second ischaemic stroke without raising bleeding-related concerns, according to preliminary...
Carotid revascularisation and medical management both fail to improve cognitive skills...
Restoring blood flow to the brain by treating carotid artery stenosis does not appear to improve patients’ cognitive skills, according to preliminary late-breaking science...
Giving post-thrombectomy alteplase within 24 hours of stroke onset shown to...
Giving the clot-busting medication alteplase at the site of a blocked brain artery after removal of a blood clot via mechanical thrombectomy may increase...
Brainomix to launch next-generation stroke platform equipped with net water uptake...
Brainomix has announced the upcoming launch of its new Brainomix 360 next-generation platform at the International Stroke Conference (ISC; 4–6 February 2026, New Orleans,...
US analysis links taking multiple antiplatelet medications to worse outcomes in...
An analysis of hospital registry data has found that people who were hospitalised due to bleeding in the brain and had taken multiple antiplatelet...
Aneurysm patients with cervical artery dissections may not face greater short-term...
Patients who developed an aneurysm with a cervical artery dissection (CeAD)—particularly young adults—did not experience an increased risk of stroke within the six months...
Electromagnetic therapy demonstrates “exciting” potential in reducing post-stroke disability
Electromagnetic network-targeted field (ENTF) therapy combined with physical therapy significantly reduces overall disability in stroke survivors compared to inactive—or ‘sham’—electromagnetic stimulation plus physical therapy,...
New ASA guideline brings ‘a decade of stroke care advances’ directly...
Expanded eligibility for advanced stroke therapies, and new recommendations on diagnosing and treating stroke in children as well as adults, are among major updates...
